Reports for GABAPENTIN
Ingredient
GABAPENTIN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2021-07-29 | 2021-11-05 | 143262 |
| APO-GABAPENTIN | 400MG | CAPSULE | Resolved | 2021-09-17 | 2021-11-22 | 145837 |
| APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-01-07 | 2022-01-31 | 152310 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-01-27 | 2022-02-05 | 153715 |
| TEVA-GABAPENTIN | 300MG | CAPSULE | Resolved | 2022-02-17 | 2022-04-21 | 155174 |
| GABAPENTIN CAPSULES USP | 100MG | CAPSULE | Resolved | 2022-01-14 | 2022-05-26 | 152800 |
| GABAPENTIN CAPSULES USP | 300MG | CAPSULE | Resolved | 2022-01-14 | 2022-05-26 | 152792 |
| GABAPENTIN CAPSULES USP | 400MG | CAPSULE | Resolved | 2022-07-08 | 2022-07-26 | 164329 |
| TEVA-GABAPENTIN | 100MG | CAPSULE | Resolved | 2022-08-18 | 2022-09-08 | 167241 |
| NEURONTIN | 800MG | TABLET | Resolved | 2022-09-01 | 2022-10-05 | 168396 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-GABAPENTIN | 100MG | CAPSULE | Discontinued | 2017-08-24 | 2017-08-24 | 20147 |
| MYLAN-GABAPENTIN | 300MG | CAPSULE | Discontinued | 2017-08-24 | 2017-08-24 | 20162 |
| MYLAN-GABAPENTIN | 800MG | TABLET | Discontinued | 2017-08-24 | 2017-09-08 | 20175 |
| MYLAN-GABAPENTIN | 600MG | TABLET | Discontinued | 2017-08-24 | 2017-09-08 | 20169 |
| MYLAN-GABAPENTIN | 400MG | CAPSULE | Discontinued | 2017-11-23 | 2017-12-02 | 30305 |
| VAN-GABAPENTIN | 100MG | CAPSULE | Discontinued | 2018-08-17 | 2018-08-17 | 58374 |
| VAN-GABAPENTIN | 300MG | CAPSULE | Discontinued | 2018-08-17 | 2018-08-17 | 58377 |
| VAN-GABAPENTIN | 400MG | CAPSULE | Discontinued | 2018-08-17 | 2018-08-17 | 58380 |
| VAN-GABAPENTIN | Discontinued | 2018-08-17 | 2018-08-17 | 58383 | ||
| VAN-GABAPENTIN | 600MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58448 |